Gastrointestinal Adverse Events Of the adverse effects reported during GLP-1 RA clinical trials, gastrointestinal symptoms were the most frequent, with nausea and diarrhea very common, and vomiting, constipation, abdominal pain, and dyspepsia considered to be relatively common [97]
cGAS/STING signaling in the regulation of rheumatoid synovial aggression
PMID 4932997
The favorable safety profile of tesofensine, demonstrated in this trial and previous studies, adds to the potential of Tesomet in treating conditions like Prader-Willi syndrome and hypothalamic obesity
If below the said age limit kindly consult your doctor first
Glutathione neutralises free radicals, reducing this damage and creating a healthier environment for hair follicles to thrive